Hepatopulmonary syndrome in inferior vena cava obstruction responding to cavoplasty.
Reports show that hepatopulmonary syndrome mostly occurs in the setting of advanced hepatic dysfunction, with the associated vasoactive substance imbalance believed to be responsible for its pathogenesis. However, hepatopulmonary syndrome has also been reported in cases of mild hepatic dysfunction or noncirrhotic portal hypertension, indicating that portal hypertension also plays a part in the pathogenesis. Liver transplantation remains the only therapeutic option of proven benefit. We describe 2 cases of hepatopulmonary syndrome in the setting of inferior vena cava (suprahepatic) obstruction, but with minimal hepatic dysfunction. After balloon cavoplasty, 1 patient showed, in addition to improvement of the features of hepatic outflow obstruction, significant reduction of dyspnea, cyanosis, and hypoxemia with arterial blood gas normalization within 2 weeks and intrapulmonary shunt reversal within 8 weeks. This implies that hemodynamic alterations (such as portal hypertension) independently contribute to the pathogenesis of hepatopulmonary syndrome in at least some of the cases. Therapies aimed at correcting these abnormal hemodynamics may be important in the treatment of this condition, especially when the hepatic functional status by itself does not warrant a liver transplant.
De
B K
BK
Department, Institute of Post Graduate Medical Education and Research, Calcutta, India.
Sen
S
S
Biswas
P K
PK
Sanyal
R
R
Majumdar
D
D
Biswas
J
J
D000328:Adult; D000800:Angioplasty, Balloon; D003251:Constriction, Pathologic / Q000150:complications / Q000628:therapy; D006439:Hemodynamics; D020065:Hepatopulmonary Syndrome / Q000150:complications* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008297:Male; D014682:Vena Cava, Inferior